Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Vaughan David Investments LLC IL Takes Position in Gilead Sciences, Inc. $GILD - Zolmax
Vaughan David Investments LLC IL Invests $33.80 Million in Gilead Sciences, Inc. $GILD - Markets Daily
Mosley Wealth Management Makes New $529,000 Investment in Gilead Sciences, Inc. $GILD - Markets Daily
Nuveen LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily
UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD - Zolmax
GILD Donates Antiviral Therapy to Support Ebola Response in Uganda
Xponance LLC Has $29.15 Million Stock Position in Gilead Sciences, Inc. $GILD
FY2026 EPS Forecast for Gilead Sciences Reduced by Analyst
Swiss National Bank Has $417.34 Million Position in Gilead Sciences, Inc. $GILD
Meiji Yasuda America Inc Takes Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Acquired by Sector Gamma AS - Daily Political
Gilead Sciences, Inc. $GILD Shares Purchased by Great Lakes Advisors LLC
Gilead Sciences, Inc. $GILD Shares Acquired by DJE Kapital AG
UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Aviva PLC Acquires 59,782 Shares of Gilead Sciences, Inc. $GILD
ASO GROUP Ltd Acquires New Holdings in Gilead Sciences, Inc. $GILD
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gilead Sciences (GILD)
CAR T-Cell Therapy for Non-Hodgkin's lymphoma Market Emerging as a High-Growth Healthcare Investment Space Through 2036 - DelveInsight | Gilead Sciences, Kite Pharma, Novartis, BMS, Allogene Therapeut
How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones
Gilead Sciences Inc (GILD) Stock Up 3.6% but GF Value Says Overv
Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now?
Gilead Sciences, Inc. $GILD Position Lessened by Zions Bancorporation National Association UT - Zolmax
Gilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD) - Stock Observer
Johnson Wealth Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD Shares Bought by Illinois Municipal Retirement Fund
Gilead Sciences, Inc. $GILD Shares Acquired by LPL Financial LLC
Recent Analysts' Ratings Changes for Gilead Sciences (GILD)
Johnson Wealth Management LLC Makes New $2.51 Million Investment in Gilead Sciences, Inc. $GILD - Stock Observer
Cerity Partners LLC Buys 19,673 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. (GILD): a Top Deep Value Stock Making Progress on Pipeline Development
Gilead Sciences Inc (GILD) Shares Fall 3.2% -- What GF Score of
Top Pharmaceutical Stocks To Watch Today - June 10th - Stock Observer
Motley Fool Asset Management LLC Buys 29,394 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by BLI Banque de Luxembourg Investments
Gilead Sciences, Inc. $GILD Shares Sold by Deutsche Bank AG - Stock Observer
Gilead Sciences Inc at Goldman Sachs Healthcare Conference Transcript
10 Deep Value Stocks to Invest In Now
Gilead Balances Trodelvy Setback With Once Weekly HIV Progress
Best Pharmaceutical Stocks To Consider - June 9th - Stock Observer
WINTON GROUP Ltd Sells 56,799 Shares of Gilead Sciences, Inc. $GILD
Franklin Resources Inc. Sells 169,087 Shares of Gilead Sciences, Inc. $GILD
Merck (MRK) and Gilead Sciences (GILD) Achieve Key Trial Milestones in HIV Treatment
Merck, Gilead End Lung Cancer Trial, Report Positive Data From HIV Drug Trials | Morningstar
Company Website: https://www.merck.com Company Website: ht
- Novel Investigational Combination Pairs Merck's Islatravir
Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study | Morningstar
Assessing Gilead Sciences (GILD) Valuation As Livdelzi Phase 3 PBC Results Shape Growth Expectations
Gilead Sciences, Inc. $GILD Shares Acquired by O Shaughnessy Asset Management LLC
Gilead Sciences, Inc. $GILD Shares Bought by Erste Asset Management GmbH
Clearbridge Investments LLC Reduces Stock Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Holdings Raised by Brandywine Global Investment Management LLC
Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now?
Top Pharmaceutical Stocks To Watch Today - June 7th - Zolmax
Best Medical Stocks To Research - June 7th - Stock Observer
Gilead Sciences, Inc. $GILD Shares Sold by Capital Research Global Investors
Capital International Inc. CA Cuts Stock Holdings in Gilead Sciences, Inc. $GILD
DB&C Advisors LLC Invests $1.57 Million in Gilead Sciences, Inc. $GILD
Los Angeles Capital Management LLC Sells 676,504 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Sciences, Inc. $GILD Shares Purchased by ING Groep NV - Daily Political
Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline
Capital World Investors Sells 2,307,802 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Expands Into Autoimmune Orphan Diseases With Ouro Medicines Deal
SpaceX IPO Could Create 'The Biggest Short Squeeze' of All Time on Index Funds. Here's How That Happens.
Vise Technologies Inc. Purchases 11,294 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by BI Asset Management Fondsmaeglerselskab A S
111 Capital Sells 7,913 Shares of Gilead Sciences, Inc. $GILD
5 Best Quality Growth Stocks to Buy
How to use the anti-HIV jab - and where to find it
Lakefront Refocuses On T Cell Engagers With Gilead Partnership Pivot
Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands - Stock Observer
Pharmaceutical Stocks To Consider - June 5th - Stock Observer
Parallel Advisors LLC Has $9.63 Million Stock Position in Gilead Sciences, Inc. $GILD - Zolmax
Prudential PLC Trims Stake in Gilead Sciences, Inc. $GILD
Cibc World Market Inc. Buys 97,779 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - Daily Political
GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
TD Asset Management Inc Sells 67,251 Shares of Gilead Sciences, Inc. $GILD
Dynasty Wealth Management LLC Invests $525,000 in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences' Employee Resource Groups Run/Walk 5k To Raise Funds for Dreams for Veterans -- Dream Foundation | PRLog
Thompson Siegel & Walmsley LLC Acquires 14,995 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Data On Livdelzi And Trodelvy Points To Broader Future Mix
Natixis Advisors LLC Grows Stock Holdings in Gilead Sciences, Inc. $GILD
Marble Wealth LLC Acquires Shares of 9,588 Gilead Sciences, Inc. $GILD - Daily Political
Insider Sell: Daniel O'Day Sells 15,000 Shares of Gilead Sciences Inc (GILD)
How Investors Are Reacting To Gilead Sciences (GILD) Expanding Liver And Oncology Drug Footprint
Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 15,000 Shares
Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis
Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety
Gilead News
New Fed Chair Kevin Warsh: Reshaping Communication and Steering Market Expectations
Goldman Sachs Revises 2027 Brent Crude Forecast to $80/bbl Amid Shifting Supply and Demand Dynamics
US CPI Preview: Higher Inflation Could Reinforce Fed Rate-Hike Bets
CFD Trading Strategies: How to Cash In on the World Cup Stock Market Curse with CFD Shorts
Latest news
Show moreQatar's Delicate Energy Diplomacy Amidst Regional Conflict: A Balancing Act
Lebanon: A Geopolitical Chessboard of Iranian Influence and US Diplomacy
BoJ Policy Meeting Under Scrutiny Amid Governor's Health, Rate Hike Expectations
US-Iran Standoff: Peak Pressure Tactics Amidst Hopes for a Diplomatic Breakthrough
